Skip to main content
Premium Trial:

Request an Annual Quote

Metabolomics Firm Metabolon Raises $13.1M

NEW YORK (GenomeWeb News) – Metabolomics firm Metabolon today announced it has completed a Series D financing round that raised $13.1 million.

New investor Keating Capital participated in the round, which also included existing investors Sevin Rosen Funds, Aurora Funds, Harris & Harris Group; Syngenta Ventures, Fletcher Spaght, and Fulcrum Financial Partners.

The Research Triangle Park, NC-based firm raised $12.3 million in a Series C round two years ago.

John Ryals, president and CEO of Metabolon, said in a statement that the funds will be used to support growth of its Metabolytics division, which provides biochemical profiling services, as well as ongoing development of Metabolon's diagnostics products portfolio.

The company, which had been primarily a service business, moved into the diagnostics space earlier this year. Its first diagnostic test, called Quantose, targets insulin-resistance and is in final CLIA validation, Todd Lynch, Metabolon's CFO said in an e-mail to GenomeWeb Daily News. He added that the test is anticipated to launch by the end of the year.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.